Disease | | -2.450 | 0.015 |
CD | 22.10+3.16 | | |
UC | 23.01+2.21 | | |
Disease duration (yr) | | 2.557 | 0.056 |
<5 | 22.84+2.99 | | |
5-9 | 22.92+2.23 | | |
10-14 | 22.44+2.33 | | |
≥15 | 21.44+3.83 | | |
Previous IBD-related hospitalization | | 0.864 | 0.389 |
Yes | 22.33+3.08 | | |
No | 22.68+2.42 | | |
Previous IBD-related surgery | | 2.126 | 0.035 |
Yes | 21.87+3.32 | | |
No | 22.80+2.50 | | |
Previous relapse history | | 0.749 | 0.455 |
Yes | 22.40+2.97 | | |
No | 22.83+2.00 | | |
Concomitant steroid use | | -5.039 | <0.001 |
Yes | 24.18+0.98 | | |
No | 22.36+2.90 | | |
Route of medications | | 2.065 | 0.040 |
PO only | 22.80+2.40 | | |
PO and parenteral | 21.98+3.34 | | |
Number of medications | | 1.478 | 0.141 |
One | 22.75+2.52 | | |
More than two | 22.17+3.15 | | |
Number of pills (per day) | | 1.198 | 0.232 |
<5 | 22.70+2.59 | | |
≥5 | 22.28+2.98 | | |
Number of doses (per day) | | 4.950 | 0.008 |
Oncea | 23.12+2.06 | | a>c* |
Twiceb | 22.68+2.99 | | |
Three or more timesc | 21.68+3.17 | | |
Outpatient visit interval (days) | | 2.300 | 0.079 |
<28 | 23.23+2.13 | | |
28-56 | 21.77+3.44 | | |
57-84 | 22.83+3.00 | | |
≥85 | 22.55+2.34 | | |
IBD education experience | | -0.952 | 0.342 |
Yes | 22.55+2.85 | | |
No | 22.05+2.90 | | |
Disease activity | | 0.307 | 0.821 |
Remission | 22.41+2.91 | | |
Mild | 22.68+2.88 | | |
Moderate | 22.77+2.46 | | |
Severe | 21.00+0.00 | | |